
Lucira Health (LHDX) Earnings Dates & Reports
Lucira Health (LHDX) Most Recent Earnings
Report Date
Period EndingQ3 2022
Est. EPS-$0.38
Actual EPS-$0.38
EarningsMeet
Lucira Health (LHDX) Earnings
View the latest Lucira Health (LHDX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Lucira Health (LHDX)
Order type
Buy in
Order amount
Est. shares
0 shares
Lucira Health (LHDX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Lucira Health (LHDX) Latest Earnings
The value each LHDX share was expected to gain vs. the value each share gained.
Lucira Health (LHDX) reported its most recent earnings on for Q3 2022, posting earnings per share (EPS) of -$0.38. This exceeded analysts' expectations of -$0.38 by 0.00%, marking a Meet.
For comparison, Lucira Health reported EPS of -$0.47 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
Lucira Health (LHDX) Earnings History
Lucira Health (LHDX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Lucira Health’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Lucira Health (LHDX) Earnings FAQs
Lucira Health (LHDX) last reported earnings on Nov 14, 2022 for Q3 2022, posting an EPS of -$0.38, which Meet the estimate of -$0.38 by 0.00%.
For Q3 2022, Lucira Health (LHDX) reported an EPS of -$0.38, missing analysts' estimate of -$0.38 by 0.00%.
For Q3 2022, Lucira Health (LHDX) Meet expectations with an actual EPS of -$0.38 vs. an estimated EPS of -$0.38.
Following the last earnings report on Nov 14, 2022, Lucira Health (LHDX)'s stock price moved — from — to —.
The next Lucira Health (LHDX) earnings call is scheduled for Nov. 14, 2022, where executives will discuss financial results and outlook.